[1] |
WHO Classification of Tumours Editorial Board. WHO classifi⁃cation of tumours. Soft tissue and bone tumours[M]. 5th ed. Lyon: International Agency for Research on Cancer, 2020:114⁃115.
|
[2] |
Anderson WJ, Mertens F, Mariño⁃Enríquez A, et al. Superficial CD34⁃positive fibroblastic tumor: a clinicopathologic, immuno⁃ histochemical, and molecular study of 59 cases[J]. Am J Surg Pathol, 2022,46(10):1329⁃1339. doi: 10.1097/PAS.000000000 0001927.
|
[3] |
李海, 刘冲, 张智弘, 等. 浅表性CD34阳性纤维母细胞肿瘤三例临床病理学特征分析[J]. 中华病理学杂志, 2019,48(2):144⁃146. doi: 10.3760/cma.j.issn.0529⁃5807.2019.02.014.
|
[4] |
Carter JM, Weiss SW, Linos K, et al. Superficial CD34⁃positive fibroblastic tumor: report of 18 cases of a distinctive low⁃grade mesenchymal neoplasm of intermediate (borderline) malignancy[J]. Mod Pathol, 2014,27(2):294⁃302. doi: 10.1038/modpathol. 2013.139.
|
[5] |
Lao IW, Yu L, Wang J. Superficial CD34⁃positive fibroblastic tumour: a clinicopathological and immunohistochemical study of an additional series[J]. Histopathology, 2017,70(3):394⁃401. doi: 10.1111/his.13088.
|
[6] |
Hendry SA, Wong DD, Papadimitriou J, et al. Superficial CD34⁃positive fibroblastic tumour: report of two new cases[J]. Pathology, 2015,47(5):479⁃482. doi: 10.1097/PAT.0000000000000281.
|
[7] |
Yamaga K, Fujita A, Osaki M, et al. Detailed analysis of a superficial CD34⁃positive fibroblastic tumor: a case report and review of the literature[J]. Oncol Lett, 2017,14(3):3395⁃3400. doi: 10.3892/ol.2017.6636.
|
[8] |
Batur S, Ozcan K, Ozcan G, et al. Superficial CD34 positive fibroblastic tumor: report of three cases and review of the literature[J]. Int J Dermatol, 2019,58(4):416⁃422. doi: 10.1111/ijd.14357.
|
[9] |
Lin TL, Yang CS, Juan CK, et al. Superficial CD34⁃positive fibroblastic tumor: a case report and review of the literature[J]. Am J Dermatopathol, 2020,42(1):68⁃71. doi: 10.1097/DAD.000 0000000001355.
|
[10] |
Mao X, Sun YY, Deng ML, et al. Superficial CD34⁃positive fibroblastic tumor: report of two cases and review of literature[J]. Int J Clin Exp Pathol, 2020,13(1):38⁃43.
|
[11] |
Foot O, Hallin M, Bagué S, et al. Superficial CD34⁃positive fibroblastic tumor[J]. Int J Surg Pathol, 2020,28(8):879⁃881. doi: 10.1177/1066896920938133.
|
[12] |
Li SY, Zhang HL, Bai YZ. Superficial CD34⁃positive fibroblastic tumor on the chest wall of an 8⁃year⁃old girl: a case report and literature review[J]. Pediatr Hematol Oncol, 2021,38(6):602⁃608. doi: 10.1080/08880018.2020.1859659.
|
[13] |
Salah HT, D′ardis JA, Baek D, et al. Superficial CD34⁃positive fibroblastic tumor (SCPFT): a review of pathological and clinical features[J]. Ann Diagn Pathol, 2022,58:151937. doi: 10.1016/j.anndiagpath.2022.151937.
|
[14] |
Hamada T, Katsuki N, Hosokawa Y, et al. Additional case of superficial CD34⁃positive fibroblastic tumor in a Japanese patient[J]. J Dermatol, 2019,46(4):e134⁃e136. doi: 10.1111/1346⁃8138.14629.
|
[15] |
Ding L, Xu WJ, Tao XY, et al. Clinicopathological features of superficial CD34⁃positive fibroblastic tumor[J]. World J Clin Cases, 2021,9(12):2739⁃2750. doi: 10.12998/wjcc.v9.i12.2739.
|
[16] |
杜秀銮, 王坚. 浅表性CD34阳性纤维母细胞肿瘤25例临床病理学分析[J]. 中华病理学杂志, 2021,50(12):1329⁃1334. doi: 10.3760/cma.j.cn112151⁃20210814⁃00569.
|
[17] |
陈源, 赵明, 汤琪乐, 等. 浅表性CD34阳性的纤维母细胞肿瘤一例[J]. 中华病理学杂志, 2017,46(3):199⁃200. doi: 10.3760/cma.j.issn.0529⁃5807.2017.03.013.
|
[18] |
庞俊伟, 闫攀攀, 马春花, 等. 浅表性CD34阳性纤维母细胞肿瘤1例并文献复习[J]. 临床与实验病理学杂志, 2018,34(8):909⁃911. doi: 10.13315/j.cnki.cjcep.2018.08.020.
|
[19] |
闫广宁, 仝桂慧, 李静, 等. 浅表性CD34阳性纤维母细胞性肿瘤一例[J]. 实用皮肤病学杂志, 2021,14(6):382⁃384. doi: 10.11786/sypfbxzz.1674⁃1293.20210618.
|
[20] |
万良斌, 冯俊明, 曾英, 等. 浅表性CD34阳性的纤维母细胞肿瘤1例报道并文献复习[J]. 诊断病理学杂志, 2020,27(5):322⁃326. doi: 10.3969/j.issn.1007⁃8096.2020.05.007.
|
[21] |
张甜, 陈兰, 汪凯, 等. 浅表性CD34阳性纤维母细胞肿瘤3例并文献复习[J]. 现代实用医学, 2021,33(2):169⁃171,封3. doi:10.3969/j.issn.1671⁃0800.2021.02.013.
|
[22] |
安晓静, 黄勇, 刘炯, 等. 浅表性CD34阳性纤维母细胞肿瘤1例报道[J]. 诊断病理学杂志, 2020,27(3):202⁃205. doi: 10.3969/j.issn.1007⁃8096.2020.03.015.
|
[23] |
朱永村, 张玉杰, 张淑坤. 浅表性CD34阳性成纤维细胞肿瘤1例[J]. 中华皮肤科杂志, 2022,55(4):343⁃344. doi: 10.35541/cjd.20200326.
|
[24] |
王湛博, 石怀银, 袁静, 等. 胃神经鞘瘤的临床及病理学特点[J]. 中华病理学杂志, 2012,41(2):97⁃101. doi: 10.3760/cma.j.issn.0529⁃5807.2012.02.006.
|
[25] |
Fedorova AS, Sidorov IV, Konovalov DM. Angiomatoid fibrous histiocytoma: a literature review and a report of two cases[J]. Arkh Patol, 2021,83(5):31⁃38. doi: 10.17116/patol20218305131.
|
[26] |
Puls F, Pillay N, Fagman H, et al. PRDM10⁃rearranged soft tissue tumor: a clinicopathologic study of 9 cases[J]. Am J Surg Pathol, 2019,43(4):504⁃513. doi: 10.1097/PAS.000000000000 1207.
|
[27] |
Perret R, Michal M, Carr RA, et al. Superficial CD34⁃positive fibroblastic tumor and PRDM10⁃rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases[J]. Histopathology, 2021,79(5):810⁃825. doi: 10.1111/his.14429.
|
[28] |
Puls F, Carter JM, Pillay N, et al. Overlapping morphological, immunohistochemical and genetic features of superficial CD34⁃positive fibroblastic tumor and PRDM10⁃rearranged soft tissue tumor[J]. Mod Pathol, 2022,35(6):767⁃776. doi: 10.1038/s41379⁃ 021⁃00991⁃8.
|
[29] |
Hofvander J, Tayebwa J, Nilsson J, et al. Recurrent PRDM10 gene fusions in undifferentiated pleomorphic sarcoma[J]. Clin Cancer Res, 2015,21(4):864⁃869. doi: 10.1158/1078⁃0432.CCR⁃14⁃2399.
|
[30] |
Hofvander J, Puls F, Pillay N, et al. Undifferentiated pleomorphic sarcomas with PRDM10 fusions have a distinct gene expression profile[J]. J Pathol, 2019,249(4):425⁃434. doi: 10.1002/path. 5326.
|